## ALB: Albemarle Corporation - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 4.3% in lower entry zone (4.0-10.0%), top 4% cross-sectional ranking. Caution: MRS_5 (-1.7%) diverging from MRS_20, watch for reversal. Outperforming sector by 2.6%. Caution: momentum weakening (-6.1% MRS).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($130.10)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 8
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Leibman Financial Services Inc. Sells 16,507 Shares of Albemarle Corporation $ALB**
- Source: MarketBeat | 20251230T124256 | Neutral | Relevance: 100%
- Leibman Financial Services Inc. reduced its stake in Albemarle Corporation (NYSE:ALB) by 33.8% in Q3, selling 16,507 shares and holding 32,364 shares worth $2.62 million. While Wall Street sentiment is cautious with a "Hold" rating and an average price target of $120.21, some firms have recently raised their targets. Albemarle recently surpassed EPS estimates and declared a quarterly dividend of $0.405 per share.

**2. Albemarleâ€™s Stock Finds Its Footing: Lithium Giant Tests Investor Patience While Eyeing the Next EV Upswing**
- Source: AD HOC NEWS | 20251231T201925 | Somewhat-Bullish | Relevance: 100%
- Albemarle's stock has shown signs of stabilization after a challenging year for lithium, with its share price grinding sideways despite a bruising downturn. Fresh price targets and upbeat long-term demand forecasts suggest a quiet repricing of the world's largest lithium producer. While investors have endured significant volatility, the market is displaying "cautious optimism" as fears recede, though hard evidence for a full recovery is still awaited.

**3. Albemarle Corp. stock underperforms Tuesday when compared to competitors**
- Source: MarketWatch | 20251230T163000 | Somewhat-Bearish | Relevance: 100%
- Shares of Albemarle Corp. (ALB) fell 1.78% to $142.01 on Tuesday, underperforming the broader market as the S&P 500 Index and Dow Jones Industrial Average also experienced declines. This marks the second consecutive day of losses for the stock.

**4. Albemarle Stock Surge: Decoding The Dynamics**
- Source: StocksToTrade | 20251230T010911 | Neutral | Relevance: 100%
- Albemarle Corporation's stock is experiencing a downturn due to market volatility, despite its critical role in lithium production for EVs. The company's recent earnings report showed robust revenue but struggled with profitability margins, though its balance sheet remains healthy. Strategic partnerships and expansions in lithium production are expected to drive long-term growth and strengthen its market position in the evolving renewable energy sector.

**5. A Battery Supply Chain ETF Quietly Returned 66%, Stomping AI Stocks**
- Source: 24/7 Wall St. | 20251229T150917 | Bullish | Relevance: 73%
- The Amplify Lithium & Battery Technology ETF (BATT) returned 66% in 2025, significantly outperforming the Nasdaq-100's 22% gain, by focusing on the diversified battery supply chain. This performance was driven by strong growth in battery material producers like Albemarle and Freeport-McMoRan, rather than just EV manufacturers. While BATT offers high growth potential in electrification, investors should be aware of its commodity volatility, geopolitical risks due to heavy Chinese exposure, and limited liquidity.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 6, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Wells Fargo | $135 | $100 | +35% |
| 2025-12-18 | Citigroup | $150 | $100 | +50% |
| 2025-12-18 | Mizuho | $132 | $110 | +20% |
| 2025-12-05 | UBS | $185 | $107 | +73% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Wells Fargo | main | Equal-Weight |
| 2025-12-18 | Citigroup | main | Neutral |
| 2025-12-18 | Mizuho | main | Neutral |
| 2025-12-05 | UBS | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($0.03M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-0.8%)
- Capital World Invest: 7.0% (+0.2%)
- Blackrock Inc.: 7.0% (-0.1%)
- State Street Corpora: 4.8% (-15.4%)
- Franklin Resources, : 2.8% (-42.8%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-6.1% 5d) with bearish MACD, trend may be turning.
2. Valuation stretched: PEG 20.8x requires aggressive growth execution.
3. Elevated short interest (12.5%): bears positioning against stock.

### Catalysts

- Analyst target momentum: 6 raises (avg +39%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 20.83 signals overvaluation risk, limited margin of safety. Balance sheet: strong liquidity (2.3x). Analyst sentiment positive (6 raises, avg +39%). Institutional flow bearish (6 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $16.6B |
| Beta | 1.43 |
| 52W Range | $49.43 - $152.08 |
| Short Interest | 12.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 20.83 |
| Forward P/E | 130.8 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 deteriorating from 10.4% to 4.3% (-6.1% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 95th percentile. MRS_5 (-1.7%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 3.7% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-0.56), momentum weakening. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.30% (CS: 96) | Strong |
| RSI_14 | 61.2 | Neutral |
| MACD Histogram | -0.56 | Bearish |
| vs SMA20 | 1.036x | Above |
| vs SMA50 | 1.185x | Above |
| vs SMA200 | 1.701x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $141.44
- **Stop Loss:** $130.10 (8.0% risk)
- **Target:** $158.45 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 126
- **Position Value:** $17,821.44
- **Portfolio %:** 17.82%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with mixed signals requiring caution. VIX at 14.95 suggests calm markets, but record repo borrowing and narrowing breadth (51.4%) indicate stress beneath the surface. Positive yield curve (+62bps) and stable economic data support risk assets, but year-end dynamics mask true liquidity conditions.*

### Earnings

**Next:** 2026-02-11 (Est: $-0.67)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.88 | $-0.19 | +78.3% |
| 2025Q2 | $-0.81 | $0.11 | +113.5% |
| 2025Q1 | $-0.68 | $-0.18 | +73.5% |
| 2024Q4 | $-0.67 | $-1.09 | -63.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*